XENETIC BIOSCIENCES, INC. (XBIO) Net margin 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-90.1%FY2025 · since FY2016: -1806.9% → -90.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -90.1% | +68.3 pp |
| FY2024 | -158.4% | +4.4 pp |
| FY2023 | -162.8% | +221.1 pp |
| FY2022 | -383.9% | +102.5 pp |
| FY2021 | -486.4% | +2006.8 pp |
| FY2020 | -2493.1% | +72363.5 pp |
| FY2019 | -74856.6% | — |
| FY2017 | -47.4% | +1759.5 pp |
| FY2016 | -1806.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice